- Home
- CYN vs SHPH Comparison
CYN vs SHPH Comparison
Compare CYN & SHPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYN
- SHPH
- Stock Information
- Founded
- CYN 2013
- SHPH 2012
- Country
- CYN United States
- SHPH United States
- Employees
- CYN N/A
- SHPH N/A
- Industry
- CYN EDP Services
- SHPH Biotechnology: Pharmaceutical Preparations
- Sector
- CYN Technology
- SHPH Health Care
- Exchange
- CYN Nasdaq
- SHPH Nasdaq
- Market Cap
- CYN 7.5M
- SHPH 3.3M
- IPO Year
- CYN 2021
- SHPH 2022
- Fundamental
- Price
- CYN $4.25
- SHPH $1.21
- Analyst Decision
- CYN
- SHPH
- Analyst Count
- CYN 0
- SHPH 0
- Target Price
- CYN N/A
- SHPH N/A
- AVG Volume (30 Days)
- CYN 34.6K
- SHPH 34.8K
- Earning Date
- CYN 11-06-2024
- SHPH 11-12-2024
- Dividend Yield
- CYN N/A
- SHPH N/A
- EPS Growth
- CYN N/A
- SHPH N/A
- EPS
- CYN N/A
- SHPH N/A
- Revenue
- CYN $79,744.00
- SHPH N/A
- Revenue This Year
- CYN $18.11
- SHPH N/A
- Revenue Next Year
- CYN $418.19
- SHPH N/A
- P/E Ratio
- CYN N/A
- SHPH N/A
- Revenue Growth
- CYN N/A
- SHPH N/A
- 52 Week Low
- CYN $2.85
- SHPH $1.03
- 52 Week High
- CYN $59.50
- SHPH $4.96
- Technical
- Relative Strength Index (RSI)
- CYN 59.44
- SHPH 41.36
- Support Level
- CYN $3.55
- SHPH $1.11
- Resistance Level
- CYN $4.36
- SHPH $1.25
- Average True Range (ATR)
- CYN 0.28
- SHPH 0.10
- MACD
- CYN 0.08
- SHPH 0.04
- Stochastic Oscillator
- CYN 87.88
- SHPH 52.94
About CYN Cyngn Inc.
Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.
About SHPH Shuttle Pharmaceuticals Holdings Inc.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.